WHO ICTRP trial
The effect of valerian on sleep quality, anxiety and depression in hemodialysis'…
IRCT201601286318N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201601286318N5 |
|---|---|
| Public title | The effect of valerian on sleep quality, anxiety and depression in hemodialysis' patients |
| Scientific title | The effect of valerian on sleep quality, anxiety and depression in hemodialysis' patients |
| Primary sponsor | Semnan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Hemodialysis patients. Dementia in other specified diseases classified elsewhere;Dementia in other specified diseases classified elsewhere |
| Interventions | Intervention 1: Group A use Valerian capsules (Sedamin 530 mg, Goldaru Co.) 60 minutes before bedtime for one month. After one month cleaning, group A will receive placebo. Participants complete questionnaires of quality of sleep, anxiety… |
| Registration date | Feb 4, 2016 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: